Cardiff Oncology Inc (CRDF) earnings · rev $593.0K
These earnings events as JSON? API free 100/dayCardiff Oncology Inc (CRDF) is a biotechnology company listed on US.
This CRDF earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported CRDF revenue for 2025-12-31 was $593.0K. Net income was -$45.9M. Revenue was down 13.2% from 2024-12-31 to 2025-12-31. CRDF currently screens at market cap $238.8M.
When the next CRDF 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 13.2% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full CRDF research stays on the stock page; the tape stays on the quote page.
CRDF earnings FAQ
What are CRDF's latest revenue and net income?
Latest cached Cardiff Oncology Inc (CRDF) revenue for Dec 31, 2025 was $593.0K. Net income was -$45.9M. Statements: https://lician.com/financials/crdf
What is CRDF's latest diluted EPS?
Latest cached Cardiff Oncology Inc (CRDF) diluted EPS for Dec 31, 2025 was -$0.69.
What period does the latest CRDF earnings print cover?
The latest cached Cardiff Oncology Inc (CRDF) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did CRDF revenue change from the prior cached period?
Cached Cardiff Oncology Inc (CRDF) revenue was down 13.2% from $683.0K (Dec 31, 2024) to $593.0K (Dec 31, 2025). Statements: https://lician.com/financials/crdf
Where are CRDF earnings listed?
Cached earnings facts for Cardiff Oncology Inc (CRDF) are listed at https://lician.com/earnings/crdf. Statements: https://lician.com/financials/crdf
Not investment advice.